Valuation: OneSource Specialty Pharma Limited

Market Cap 181B 1.89B 1.65B 1.56B 1.42B 2.65B 2.66B 18.57B 7.18B 92.06B 7.11B 6.95B 295B P/E 2027 *
39x
P/E 2028 * 18.9x
Enterprise Value 190B 1.98B 1.73B 1.64B 1.49B 2.78B 2.79B 19.48B 7.53B 96.56B 7.45B 7.29B 309B EV / Sales 2027 *
8.72x
EV / Sales 2028 * 5.36x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day-1.04%
1 week+3.26%
Current month+4.01%
1 month+1.33%
3 months-1.24%
6 months+5.81%
Current year-12.74%
1 week 1,530
Extreme 1530
1,657.5
1 month 1,478
Extreme 1478
1,657.5
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Chairman 65 22/09/2025
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+3.26%-14.16% - 1.91B
+1.23%+1.87%-0.15%+28.45% 45.91B
+0.99%+5.65%+45.61%+29.85% 44.25B
+0.32%-3.13%+349.62%+536.86% 41.99B
+1.16%+3.09%+6.07%+68.67% 39.58B
+1.75%-1.53%+12.22%+41.11% 31.08B
+0.89%+6.51%+24.77%+127.43% 17.21B
-3.26%-8.46% - - 16.27B
+2.92%+8.40%+22.46%+39.73% 14.96B
-0.39%+4.32%-1.35%-34.29% 13.42B
Average +0.48%+1.82%+49.45%+104.73% 26.66B
Weighted average by Cap. +0.83%+0.71%+72.03%+126.78%

Financials

2027 *2028 *
Net sales 21.8B 228M 198M 188M 170M 318M 320M 2.23B 864M 11.08B 855M 836M 35.46B 34.02B 355M 309M 293M 266M 497M 499M 3.49B 1.35B 17.29B 1.33B 1.3B 55.35B
Net income 4.46B 46.56M 40.55M 38.38M 34.87M 65.15M 65.47M 457M 177M 2.27B 175M 171M 7.25B 8.97B 93.65M 81.56M 77.2M 70.14M 131M 132M 919M 356M 4.56B 352M 344M 14.59B
Net Debt 8.86B 92.47M 80.54M 76.23M 69.26M 129M 130M 908M 351M 4.5B 347M 340M 14.41B 1.16B 12.15M 10.59M 10.02M 9.1M 17.01M 17.09M 119M 46.14M 592M 45.66M 44.64M 1.89B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,674
Date Price Change Volume
17/09/26 1,580.00 -1.04% 121,361
16/09/26 ₹1,596.60 -0.19% 143,256
15/09/26 ₹1,599.60 +0.46% 724,751
11/09/26 ₹1,592.20 +3.26% 919,086
10/09/26 ₹1,541.90 +0.77% 247,132
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,580.00INR
Average target price
2,056.00INR
Spread / Average Target
+30.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!